Savaria (TSE:SIS) Sets New 52-Week High Following Analyst Upgrade

Savaria Co. (TSE:SIS) hit a new 52-week high on Friday after ATB Cormark Capital Markets raised their price target on the stock from C$30.00 to C$32.00. ATB Cormark Capital Markets currently has an outperform rating on the stock. Savaria traded as high as C$26.42 and last traded at C$26.41, with a volume of 636433 shares changing hands. The stock had previously closed at C$24.32.

Several other brokerages have also weighed in on SIS. Desjardins lifted their price objective on Savaria from C$27.00 to C$32.00 and gave the stock a “buy” rating in a report on Friday. Stifel Nicolaus upped their price objective on shares of Savaria from C$28.00 to C$29.00 and gave the company a “buy” rating in a report on Friday. Scotiabank increased their target price on shares of Savaria from C$29.00 to C$30.00 and gave the stock an “outperform” rating in a research report on Friday. TD Securities lifted their target price on shares of Savaria from C$27.00 to C$31.00 and gave the stock a “buy” rating in a research note on Thursday. Finally, National Bank Financial boosted their price target on shares of Savaria from C$30.00 to C$30.50 and gave the company an “outperform” rating in a research report on Friday. Seven analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company has an average rating of “Buy” and an average price target of C$30.93.

Trending Headlines about Savaria

Here are the key news stories impacting Savaria this week:

• Positive Sentiment: Multiple brokerages raised price targets and upgraded ratings this morning (ATB Cormark to C$32, Raymond James to C$32, National Bank to C$30.50, Scotiabank to C$30, Desjardins to C$32, Stifel and TD also higher). These raises signal stronger analyst confidence and imply double?digit upside from current levels. Analyst Rating Roundup
• Positive Sentiment: Savaria reported record 2025 results and stronger margins, with Q4 revenue of C$241.8M and EPS C$0.37 — results the company says position it for a new growth phase around its Savaria One strategy. This fundamental momentum underpins the analyst upgrades. Record 2025 Results
• Positive Sentiment: Coverage pieces note Savaria “entering a new growth phase” after completion of Savaria One and record Q4, reinforcing the narrative for higher future growth and margin improvement. Growth Phase Article
• Neutral Sentiment: The shares briefly hit a 12?month high following the analyst activity and results, attracting attention from retail and institutional traders. 12?Month High Coverage
• Neutral Sentiment: Management’s earnings release and conference call are available for review (detailed Q4 release and call transcript), useful for investors who want to assess guidance and cadence of margin improvement. Press Release / Transcript
• Negative Sentiment: Despite the positive newsflow, the stock is lower — likely reflecting short?term profit?taking after a run to a 52?week high, elevated trading volume, and valuation concerns (current reported P/E ~29 and very high PEG). Those factors can pressure the share price even amid upgrades. Market Data / Valuation

Savaria Price Performance

The company has a current ratio of 1.61, a quick ratio of 0.91 and a debt-to-equity ratio of 8.27. The stock has a market capitalization of C$1.83 billion, a PE ratio of 29.33, a PEG ratio of 42.72 and a beta of 1.14. The business has a fifty day moving average price of C$24.64 and a 200-day moving average price of C$22.52.

Savaria (TSE:SIS) last announced its quarterly earnings data on Wednesday, March 4th. The company reported C$0.37 earnings per share for the quarter. The company had revenue of C$241.78 million for the quarter. Savaria had a return on equity of 11.10% and a net margin of 7.53%. Research analysts expect that Savaria Co. will post 1.2048518 EPS for the current fiscal year.

Savaria Company Profile

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.